SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Operating Lease, Payments
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Operating Lease, Payments of $24.09 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, payments for the quarter ending 2026-06-30 was $24.09K, a 3.00% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, payments for the quarter ending 2026-03-31 was $23.85K, a 3.00% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, payments for the quarter ending 2025-12-31 was $23.85K, a 3.00% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, payments for the quarter ending 2025-09-30 was $23.85K, a 3.00% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, payments for fiscal 2025 was $94.25K, a 3.00% increase from fiscal 2024.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, payments for fiscal 2024 was $91.50K, a 4.33% decline from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, payments for fiscal 2023 was $95.64K, a 25.43% increase from fiscal 2022.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, payments for fiscal 2022 was $76.25K.
| Period end | Operating Lease, Payments 0 month | Operating Lease, Payments 0 month as first filed | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24.09K 10-Q · filed 2026-09-24 | $47.94K 10-Q · filed 2026-09-24 | $71.79K derived: sum of 3 quarters · filed 2026-09-24 | $95.64K derived: sum of 4 quarters · filed 2026-09-24 | ||
| 2026-03-31 | $23.85K 10-Q · filed 2026-05-15 | $47.70K derived: sum of 2 quarters · filed 2026-05-15 | $71.55K derived: sum of 3 quarters · filed 2026-05-15 | $94.94K derived: sum of 4 quarters · filed 2026-09-24 | ||
| 2025-12-31 | $23.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $47.70K derived: sum of 2 quarters · filed 2026-03-31 | $71.09K derived: sum of 3 quarters · filed 2026-09-24 | $94.25K 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $23.85K 10-Q · filed 2025-11-13 | $47.24K derived: sum of 2 quarters · filed 2026-09-24 | $70.39K 10-Q · filed 2025-11-13 | $93.55K derived: sum of 4 quarters · filed 2026-09-24 | ||
| 2025-06-30 | $23.39K 10-Q · filed 2026-09-24 | $46.54K 10-Q · filed 2026-09-24 | $69.70K derived: sum of 3 quarters · filed 2026-09-24 | $92.86K derived: sum of 4 quarters · filed 2026-09-24 | ||
| 2025-03-31 | $23.16K 10-Q · filed 2026-05-15 | $46.31K derived: sum of 2 quarters · filed 2026-05-15 | $69.47K derived: sum of 3 quarters · filed 2026-05-15 | $92.18K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $23.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $46.31K derived: sum of 2 quarters · filed 2026-03-31 | $69.02K derived: sum of 3 quarters · filed 2026-03-31 | $91.50K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $23.16K 10-Q · filed 2025-11-13 | $45.86K derived: sum of 2 quarters · filed 2025-11-13 | $68.34K 10-Q · filed 2025-11-13 | $90.10K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $22.71K 10-Q · filed 2025-08-13 | $45.19K 10-Q · filed 2025-08-13 | $66.95K derived: sum of 3 quarters · filed 2025-08-13 | $98.06K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $22.48K 10-Q · filed 2025-05-08 | $44.24K derived: sum of 2 quarters · filed 2025-05-08 | $75.35K derived: sum of 3 quarters · filed 2025-05-08 | $98.68K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $21.76K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $52.87K derived: sum of 2 quarters · filed 2025-02-26 | $76.20K derived: sum of 3 quarters · filed 2025-02-26 | $95.64K 10-K · filed 2025-02-26 | ||
| 2023-09-30 | $31.11K 10-Q · filed 2024-11-13 | $54.44K derived: sum of 2 quarters · filed 2024-11-13 | $73.88K 10-Q · filed 2024-11-13 | $93.52K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $23.33K 10-Q · filed 2024-09-04 | $42.77K 10-Q · filed 2024-09-04 | $62.40K derived: sum of 3 quarters · filed 2024-09-04 | $81.27K derived: sum of 4 quarters · filed 2024-09-04 | ||
| 2023-03-31 | $19.44K 10-Q/A · filed 2024-09-04 | $39.07K derived: sum of 2 quarters · filed 2024-09-04 | $57.94K derived: sum of 3 quarters · filed 2024-09-04 | $76.81K derived: sum of 4 quarters · filed 2024-09-04 | ||
| 2022-12-31 | $19.63K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-04 | $38.50K derived: sum of 2 quarters · filed 2024-09-04 | $57.38K derived: sum of 3 quarters · filed 2024-09-04 | $76.25K 10-K/A · filed 2024-09-04 | ||
| 2022-09-30 | $18.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $37.74K derived: sum of 2 quarters · filed 2023-11-13 | $56.62K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $18.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $37.75K 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $18.87K 10-Q · filed 2023-05-25 | |||||
| 2018-10-01 | $6.48K 10-K · filed 2023-03-15 | $6.29K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |